Menu

 


Project Title:  rHealth One Flight Demonstration Reduce
Images: icon  Fiscal Year: FY 2020 
Division: Human Research 
Research Discipline/Element:
HRP ExMC:Exploration Medical Capabilities
Start Date: 11/18/2019  
End Date: 06/18/2021  
Task Last Updated: 01/28/2020 
Download report in PDF pdf
Principal Investigator/Affiliation:   Zoldak, John   / Zin Technologies, Inc. 
Address:  GRC-MS00 
6745 Engle Road 
Cleveland , OH 44130-7994 
Email: zoldakj@zin-tech.com 
Phone: 440.625.2334  
Congressional District: 16 
Web:  
Organization Type: INDUSTRY 
Organization Name: Zin Technologies, Inc. 
Joint Agency:  
Comments:  
Co-Investigator(s)
Affiliation: 
Lewandowski, Beth  Ph.D. NASA Glenn Research Center  
Project Information: Grant/Contract No. Directed Research 
Responsible Center: NASA JSC 
Grant Monitor: Lehnhardt, Kris  
Center Contact: 281.244.0524 
kris.lehnhardt@nasa.gov 
Solicitation: Directed Research 
Grant/Contract No.: Directed Research 
Project Type: FLIGHT 
Flight Program:  
TechPort: Yes 
No. of Post Docs:  
No. of PhD Candidates:  
No. of Master's Candidates:  
No. of Bachelor's Candidates:  
No. of PhD Degrees:  
No. of Master's Degrees:  
No. of Bachelor's Degrees:  
Human Research Program Elements: (1) ExMC:Exploration Medical Capabilities
Human Research Program Risks: (1) Medical:Risk of Adverse Health Outcomes & Decrements in Performance due to Inflight Medical Conditions (IRP Rev I)
Human Research Program Gaps: (1) Med12:We do not have the capability to mitigate select medical conditions (IRP Rev I)
Task Description: For current spaceflight missions, NASA has the ability to return blood and urine samples to the ground for testing and evaluation. For long duration space missions, it will not be possible for ground testing of these flight samples. There is a need to evaluate if Commercial-Off-the-Shelf (COTS) medical devices, which can assay biologic fluids, function correctly in microgravity. The rHealth ONE platform will be certified for flight using the International Space Station (ISS) Commercial-Off-the-Shelf process. Vendor will perform minor modifications to the device to conform to flight certification requirements and to ensure ease of use for the crew (simpler fluid capture/containment and minimal user interaction). The flight device will demonstrate detection of a variety of relevant particulate matter in a control solution that is representative of blood cells and rHEALTH’s proprietary nanostrips for soluble analytes. Those flight measurements will be compared to simultaneous ground measurements taken of the same batched control solution. The on-orbit demonstration will show that the rHealth ONE operates nominally in the microgravity environment.

Rationale for HRP Directed Research: This research is directed because it contains highly constrained research. In Planning, Programming, Budgeting, and Execution (PPBE) 20, Exploration Medical Capability (ExMC) Human Research Program (HRP) element planned an ISS blood analysis technology demonstration in FY20. The rHealth ONE is the implementation of that scope of work. Task complies with the intent of Technology Development activities. Task TRL (Technology Readiness Level) is 5/6.

Research Impact/Earth Benefits:

Task Progress & Bibliography Information FY2020 
Task Progress: New project for FY2020.

Bibliography Type: Description: (Last Updated: )  Show Cumulative Bibliography Listing
 
 None in FY 2020